HIMCH
VRTX icon

Hartford Investment Management Co (HIMCO)’s Vertex Pharmaceuticals VRTX Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.97M Sell
14,038
-451
-3% -$200K 0.2% 88
2026
Q1 		$6.47M Sell
14,489
-173
-1% -$80.7K 0.21% 92
2025
Q4 		$6.65M Sell
14,662
-360
-2% -$155K 0.2% 94
2025
Q3 		$5.88M Sell
15,022
-476
-3% -$199K 0.18% 104
2025
Q2 		$6.9M Sell
15,498
-172
-1% -$79.3K 0.22% 89
2025
Q1 		$7.6M Sell
15,670
-251
-2% -$117K 0.26% 80
2024
Q4 		$6.41M Sell
15,921
-329
-2% -$153K 0.21% 90
2024
Q3 		$7.56M Sell
16,250
-284
-2% -$136K 0.25% 77
2024
Q2 		$7.75M Sell
16,534
-121
-0.7% -$52.5K 0.27% 76
2024
Q1 		$6.96M Sell
16,655
-701
-4% -$296K 0.25% 84
2023
Q4 		$7.06M Sell
17,356
-356
-2% -$132K 0.26% 80
2023
Q3 		$6.16M Sell
17,712
-469
-3% -$164K 0.25% 88
2023
Q2 		$6.4M Sell
18,181
-3,476
-16% -$1.17M 0.24% 90
2023
Q1 		$6.82M Sell
21,657
-2,598
-11% -$779K 0.23% 95
2022
Q4 		$7M Sell
24,255
-90
-0.4% -$27.4K 0.21% 100
2022
Q3 		$7.05M Sell
24,345
-159
-0.6% -$45.7K 0.23% 93
2022
Q2 		$6.91M Buy
24,504
+420
+2% +$112K 0.21% 97
2022
Q1 		$6.29M Sell
24,084
-1,712
-7% -$406K 0.16% 125
2021
Q4 		$5.67M Buy
25,796
+1,605
+7% +$312K 0.13% 154
2021
Q3 		$4.39M Sell
24,191
-3,058
-11% -$597K 0.12% 171
2021
Q2 		$5.49M Sell
27,249
-1,135
-4% -$237K 0.14% 156
2021
Q1 		$6.1M Sell
28,384
-1,280
-4% -$281K 0.16% 133
2020
Q4 		$7.01M Buy
29,664
+2,495
+9% +$572K 0.19% 119
2020
Q3 		$7.39M Sell
27,169
-930
-3% -$257K 0.25% 81
2020
Q2 		$8.16M Buy
28,099
+212
+0.8% +$57.5K 0.29% 73
2020
Q1 		$6.64M Buy
27,887
+1,009
+4% +$231K 0.23% 106
2019
Q4 		$5.88M Sell
26,878
-664
-2% -$134K 0.15% 156
2019
Q3 		$4.67M Sell
27,542
-262
-0.9% -$46.3K 0.13% 189
2019
Q2 		$5.1M Buy
27,804
+173
+0.6% +$30.2K 0.14% 173
2019
Q1 		$5.08M Sell
27,631
-1,662
-6% -$307K 0.14% 163
2018
Q4 		$4.85M Buy
29,293
+922
+3% +$160K 0.15% 145
2018
Q3 		$5.47M Sell
28,371
-1,660
-6% -$296K 0.16% 149
2018
Q2 		$5.1M Sell
30,031
-19,440
-39% -$3.01M 0.16% 160
2018
Q1 		$8.06M Sell
49,471
-3,777
-7% -$617K 0.16% 161
2017
Q4 		$7.98M Sell
53,248
-815
-2% -$121K 0.15% 164
2017
Q3 		$8.22M Buy
54,063
+159
+0.3% +$23.9K 0.16% 162
2017
Q2 		$6.95M Sell
53,904
-1,879
-3% -$226K 0.13% 190
2017
Q1 		$6.1M Sell
55,783
-3,982
-7% -$351K 0.11% 221
2016
Q4 		$4.4M Buy
59,765
+359
+0.6% +$29.2K 0.08% 301
2016
Q3 		$5.18M Buy
59,406
+783
+1% +$74K 0.1% 243
2016
Q2 		$5.04M Sell
58,623
-976
-2% -$84.3K 0.11% 230
2016
Q1 		$4.74M Buy
59,599
+379
+0.6% +$34.3K 0.1% 243
2015
Q4 		$7.45M Sell
59,220
-1,649
-3% -$199K 0.16% 150
2015
Q3 		$6.34M Buy
60,869
+562
+0.9% +$72.2K 0.14% 173
2015
Q2 		$7.45M Buy
60,307
+1,578
+3% +$199K 0.15% 164
2015
Q1 		$6.93M Sell
58,729
-1,508
-3% -$181K 0.14% 177
2014
Q4 		$7.16M Sell
60,237
-676
-1% -$76.1K 0.14% 165
2014
Q3 		$6.84M Sell
60,913
-1,370
-2% -$130K 0.15% 166
2014
Q2 		$5.9M Sell
62,283
-1,227
-2% -$86K 0.12% 200
2014
Q1 		$4.49M Sell
63,510
-768
-1% -$60.8K 0.09% 248
2013
Q4 		$4.78M Sell
64,278
-3,858
-6% -$269K 0.1% 225
2013
Q3 		$5.17M Buy
68,136
+45,791
+205% +$3.64M 0.11% 214
2013
Q2 		$1.78M Buy
+22,345
New +$1.65M 0.04% 432

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s VRTX Position: Q2 2026 in Review

Hartford Investment Management Co (HIMCO) reduced its Vertex Pharmaceuticals (VRTX) stake by 3.1% in Q2 2026, selling an estimated $200K and leaving 14,038 shares worth $6.97M. The position accounts for 0.2% of the portfolio, ranked #88.

Hartford Investment Management Co (HIMCO) first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.22M in Q3 2017. 983 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Hartford Investment Management Co (HIMCO) held 14,038 shares of Vertex Pharmaceuticals worth $6.97M as of Q2 2026.
  • Hartford Investment Management Co (HIMCO) sold 451 Vertex Pharmaceuticals shares in Q2 2026, an estimated $200K.
  • Vertex Pharmaceuticals made up 0.2% of Hartford Investment Management Co (HIMCO)'s portfolio in Q2 2026, its #88 holding.
  • Hartford Investment Management Co (HIMCO) first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Hartford Investment Management Co (HIMCO)'s Vertex Pharmaceuticals position peaked at $8.22M in Q3 2017.
  • 983 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2026, filed 15 Jul 2026.